• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶原复合物浓缩剂

Prothrombin complex concentrate.

作者信息

DeWitt R T, Feinstein D I

出版信息

Arch Intern Med. 1977 Sep;137(9):1211-3.

PMID:901090
Abstract

A hemophilliac with a factor VIII inhibitor was bleeding massively from an extensive surgical wound. After ten days of unsuccessful management by conservative measures, he was given a single infusion of prothrombin complex concentrate (Konyne). Bleeding stopped immediately and the wound healed without further recurrence of bleeding. Although the activated partial thromboplastin time shortened following the infusion, the exact physiologic mechanism whereby these concentrates bypass the need for factor VIII clotting activity is unknown.

摘要

一名患有因子 VIII 抑制剂的血友病患者因大面积手术伤口大量出血。在采取保守措施治疗十天无果后,给他单次输注了凝血酶原复合物浓缩剂(科宁)。出血立即停止,伤口愈合且未再次出血。尽管输注后活化部分凝血活酶时间缩短,但这些浓缩剂绕过对因子 VIII 凝血活性需求的确切生理机制尚不清楚。

相似文献

1
Prothrombin complex concentrate.凝血酶原复合物浓缩剂
Arch Intern Med. 1977 Sep;137(9):1211-3.
2
Increased fibrinopeptide A after prothrombin complex concentrates.凝血酶原复合物浓缩剂使用后纤维蛋白肽A升高。
Thromb Haemost. 1980 Oct 31;44(2):72-5.
3
[Treatment of patients with hemophilia A having antibodies to factor VIII].[对患有抗凝血因子VIII抗体的甲型血友病患者的治疗]
Acta Haematol Pol. 1979 Apr-Jun;10(2):115-22.
4
Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.
N Engl J Med. 1974 Nov 14;291(20):1087.
5
[Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].[重组活化凝血因子VII(诺和七,诺和诺德公司)用于获得性凝血因子VIII抑制物血友病的止血治疗]
Schweiz Med Wochenschr. 1995 Mar 4;125(9):405-11.
6
[Emergency treatment of haemophilia A with factor VIII inhibitors using activated prothrombin complex concentrates (author's transl)].
Dtsch Med Wochenschr. 1977 Mar 4;102(9):319-23. doi: 10.1055/s-0028-1104885.
7
Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.凝血酶原复合物浓缩剂在伴有抗凝血因子VIII抗体的血友病患者中的疗效:一项多中心治疗试验。
N Engl J Med. 1980 Aug 21;303(8):421-5. doi: 10.1056/NEJM198008213030803.
8
Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
J Pediatr. 1976 Feb;88(2):200-5. doi: 10.1016/s0022-3476(76)80982-1.
9
The use of non-activated prothrombin concentrate in the management of haemophilia A with factor VIII antibodies.非活化凝血酶原复合物浓缩物在伴有Ⅷ因子抗体的甲型血友病治疗中的应用。
Aust N Z J Med. 1977 Jun;7(3):286-90. doi: 10.1111/j.1445-5994.1977.tb03688.x.
10
[Treatment of haemorrhages in a haemophiliac with factor-VIII inhibitor (author's transl)].
Dtsch Med Wochenschr. 1979 Feb 2;104(5):182-6. doi: 10.1055/s-0028-1103867.

引用本文的文献

1
Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors.活化的凝血酶原复合物浓缩物治疗伴有抑制剂的先天性血友病患者的起源、发展、当前挑战和未来方向。
Hamostaseologie. 2020 Dec;40(5):606-620. doi: 10.1055/a-1159-4273. Epub 2020 Jul 27.